|
|
|
|
FuzeonEurekAlert (press release), Exciting interim data presented at the annual ICAAC* conference show that adding FUZEON (enfuvirtide) to the investigational boosted protease inhibitor (PI ... Roche's Fuzeon/PI more than halves number of patients with ... Dec 20, 2005 Forbes BASEL (AFX) - Roche Holding AG said new interim data on HIV treatment Fuzeon (enfuvirtide) boosted by protease inhibitor (PI) TMC114/r shows more than a ... New Data Show Two-Thirds of Patients Achieve Undetectable Viral ... Dec 19, 2005 PR Newswire (press release), ...an experimental boosted protease inhibitor (PI), TMC-114/ritonavir, were achieved in patients who initiated the drug in combination with FUZEON(R) (enfuvirtide ... Investigational Boosted Protease Inhibitor, TMC114, Works Better ... Dec 20, 2005 APA OTS (Pressemitteilung), Basel, Switzerland (ots/PRNewswire) - - Power of "FUZEON effect" Provides Much Needed Hope for HIV Patients Facing Treatment Failure Exciting interim data ... Biotechnology drug costs scrutinized Jan 3, 2006 Ventura County Star (subscription), ...for anemia, which costs about $36,000 a year, Serono SA and Pfizer Inc.'s Rebif for multiple sclerosis, at $25,000 a year, and Roche AG's Fuzeon for AIDS ... (PRN) - Noble Appoints Andrew J. Tavi Deputy General Counsel ... ... Dec 19, 2005 Bolsamania.com, ...[+]. (PRN) - New Data Show Two-Thirds of Patients Achieve Undetectable Viral Load With FUZEON(R) and Investigational Protease Inhibitor ... [+. ... Investigative Protease Inhibitor TMC114/R Overcomes Resistance in ... Dec 22, 2005 DG News Among patients who received enfuvertide (Fuzeon) for the first time along with TMC114 at the highest dose twice-daily, 64% achieved undetectable levels of HIV ... (PRN) - Penwest Announces Results of Phase IIa Trial for PW2132 .. ... Dec 20, 2005 Bolsamania.com, Percent ... [+. PRN) - Investigational Boosted Protease Inhibitor, TMC114, Works Better in Combination With FUZEON(R) ... [. PRN ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |